MDWerks director granted 46,546 stock shares

Blackstone Richard reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/29/2026 - 04:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Blackstone Richard reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Richard Blackstone received a grant of 46,546 shares of common stock at $0.13 per share. These shares were issued on a quarterly basis under his Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, with board approval under Rule 16b-3. Following this compensation award, he directly holds 956,132 common shares.

Insider Trade Summary

Grant/Award: 46,546 shares

Grant/Award 1 txn

Insider Blackstone Richard

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46,546	$0.13	$6K

Holdings After Transaction: Common Stock — 956,132 shares (Direct)

Holdings Before and After: Common Stock, 909,586 to 956,132 shares (Direct)

Footnotes (1)

1. F1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on December 3, 2024 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

Key Figures

Shares granted: 46,546 shares Grant price: $0.13 per share Post-transaction holdings: 956,132 shares +2 more

5 metrics

Shares granted 46,546 shares Common stock grant on May 15, 2026

Grant price $0.13 per share Value per share for the common stock grant

Post-transaction holdings 956,132 shares Total common shares directly held after grant

Transaction code A (grant/award acquisition) Indicates non-derivative equity compensation

Quarterly issuance Employment-based grant Issued on a quarterly basis under Employment Agreement

Key Terms

Employment Agreement, MDWerks, Inc. 2025 Equity Incentive Plan, Rule 16b-3

3 terms

Employment Agreement financial

"issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer"

MDWerks, Inc. 2025 Equity Incentive Plan financial

"issued under the MDWerks, Inc. 2025 Equity Incentive Plan"

Rule 16b-3 regulatory

"issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MDWerks (MDWK) report for Richard Blackstone?

MDWerks reported that director Richard Blackstone received a grant of 46,546 shares of common stock. The award was issued as quarterly compensation under his Employment Agreement and the company’s 2025 Equity Incentive Plan, rather than as an open-market stock purchase.

At what price were Richard Blackstone’s MDWerks (MDWK) shares granted?

The 46,546 common shares granted to Richard Blackstone were valued at $0.13 per share. This value appears in the Form 4 as the transaction price per share, reflecting the grant’s accounting value for this equity compensation transaction disclosed by the company.

How many MDWerks (MDWK) shares does Richard Blackstone hold after this grant?

After the equity grant, Richard Blackstone directly holds 956,132 shares of MDWerks common stock. This total includes the 46,546-share quarterly award reported in the Form 4 and represents his direct ownership position immediately following the reported transaction date.

Was the MDWerks (MDWK) share grant to Richard Blackstone board-approved?

Yes. The footnote states the grant was approved by MDWerks’ board of directors and issued in accordance with Rule 16b-3. It was made pursuant to Blackstone’s Employment Agreement and under the MDWerks, Inc. 2025 Equity Incentive Plan as part of his compensation.

Is Richard Blackstone’s MDWerks (MDWK) Form 4 transaction a market buy or compensation grant?

The Form 4 describes this as a grant or award acquisition, not a market purchase. Shares were issued on a quarterly basis under his Employment Agreement and the 2025 Equity Incentive Plan, indicating routine equity compensation rather than an open-market stock-buying decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blackstone Richard

(Last) (First) (Middle)

411 WALNUT STREET, SUITE 20125

(Street)

GREEN COVE SPRINGS, FLORIDA 32043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		46,546(1)	A	$0.13	956,132	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on December 3, 2024 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

	/s/ Richard Blackstone	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)